Sanofi has previously taken other measures to make it easier for diabetes patients and payers to access insulin products, including the launch of an unbranded insulin glargine last year at a 60% ...

Its main competitors in the insulin market, Novo Nordisk and Eli Lilly, in recent years launched blockbuster weight-loss drugs that have sent their market values soaring. Hudson said Sanofi does ...

Insulin manufacturers named in the suit are Eli Lilly, Novo Nordisk and Sanofi. PBMs named in the ... process they set in the marketplace for the products they manufacture. "Nothing in our ...

Insulin makers Eli Lilly & Co. Sanofi and Novo Nordisk “have sharply inflated the list price of their insulin products in ...

has guaranteed that Wyoming residents not enrolled in government healthcare programs can buy insulin products for $35 each month for the next five years. The settlement announced by Attorney ...